A slide from a study titled "A multimeter Randomized Double-Blind Placebo-Controlled Parallel-Group Study Comparing the Efficiency and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine". The slide has a light green background with a white border. The title of the study is written in bold black font at the top of the slide. Below the title there is a subtitle in smaller black font that reads "Primary Outcome Measures". The slide also includes a table with three columns. The first column lists primary outcome measures the second column shows secondary outcome measures and the third column shows the percentage of patients reaching at least 50% reduction in the monthly average number of days of use of any acute. The table also mentions that the study was conducted by the University of Texas at Austin Texas. At the bottom of the page there are two bullet points that explain the study's findings.

• Advertisement

• Outreach and Education